<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05044351</url>
  </required_header>
  <id_info>
    <org_study_id>Autofluorescence2.0</org_study_id>
    <nct_id>NCT05044351</nct_id>
  </id_info>
  <brief_title>Near-infrared Autofluorescence (NIRAF) in Thyroid Lobectomy: Impact in Low-volume, Non-parathyroid Centers</brief_title>
  <official_title>Prevention of Postoperative Hypoparathyroidism Following Thyroid Surgery by Using Intraoperative Autofluorescence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital West Jutland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital of South West Jutland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regional Hospital West Jutland</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parathyroid damage and inadvertent excision unfortunately happens frequently in thyroid&#xD;
      surgery. The use of near-infrared autofluorescence (NIRAF) intraoperatively, seems to be&#xD;
      helpful in terms of parathyroid identification and preservation.&#xD;
&#xD;
      In order to cover every aspect of the impact of NIRAF in thyroid surgery, an evaluation in&#xD;
      low-volume, non-parathyroid centers is needed:&#xD;
&#xD;
      Aim: To investigate the impact of NIRAF on thyroid lobectomy by evaluating parathyroid&#xD;
      identification, damage and the rate of inadvertent parathyroid excision in low-volume,&#xD;
      non-parathyroid centers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients referred for thyroid lobectomy will be randomized to either:&#xD;
&#xD;
      (A) NIRAF-assisted surgery (Fluobeam LX) or (B) Conventional thyroid surgery. PTH and ionized&#xD;
      calcium will assessed preoperatively, on postoperative day 1 (POD1) and 2 months following&#xD;
      surgery. Parathyroid identification rates, rates of autoimplantation and inadvertently&#xD;
      excised parathyroid glands will be assessed and compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Clinical Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of inadvertent parathyroid excision</measure>
    <time_frame>Will be assessed one month following surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parathyroid identification rate</measure>
    <time_frame>Will be assessed at the time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of autotransplantation</measure>
    <time_frame>Will be assessed at the time of surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Autofluorescence</condition>
  <condition>Thyroidectomy</condition>
  <condition>Autotransplantation</condition>
  <arm_group>
    <arm_group_label>(A): NIRAF-assisted surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing NIRAF-assisted thyroid lobectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(B): Conventional surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing conventional thyroid surgery without NIRAF-assistance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fluobeam LX</intervention_name>
    <description>See arm description</description>
    <arm_group_label>(A): NIRAF-assisted surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional surgery without NIRAF assistance</intervention_name>
    <description>Patients undergoing conventional thyroid lobectomy without NIRAF-assistance</description>
    <arm_group_label>(B): Conventional surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients referred for thyroid lobectomy&#xD;
&#xD;
          -  Age &gt; 18&#xD;
&#xD;
          -  Able to understand patient information&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Completion lobectomy&#xD;
&#xD;
          -  Need for accelerated surgery&#xD;
&#xD;
          -  Insufficient biochemical profile&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ali Abood, MD</last_name>
    <phone>+4578439744</phone>
    <email>aliabo@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Therese Ovesen, MD, DMSc</last_name>
    <phone>+4578439744</phone>
    <email>theroves@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Otorhinolaryngology, Hospital South West Jutland</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Bach, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Otorhinolaryngology, Regional Hospital West Jutland</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Abood, MD</last_name>
      <phone>+4578439744</phone>
      <email>aliabo@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regional Hospital West Jutland</investigator_affiliation>
    <investigator_full_name>Ali Abood</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

